CV6 Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3.39M

  • Investors
  • 6

CV6 Therapeutics General Information

Description

Operator of a drug development company intended to treat human diseases and cancer. The company analyzes cancer cells for the identification of new drug targets that exploit key vulnerabilities in cancer cells and to overcome the problem of chemotherapy resistance, enabling researchers and medical professionals to develop therapeutics and improve the lives of patients with cancer and inflammatory diseases.

Contact Information

Website
www.cv6t.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Health Sciences Building, Centre for Cancer Research & Cell Biology
  • 97 Lisburn Road
  • Belfast BT9 7AE
  • Northern Ireland, United Kingdom
+44 028
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Health Sciences Building, Centre for Cancer Research & Cell Biology
  • 97 Lisburn Road
  • Belfast BT9 7AE
  • Northern Ireland, United Kingdom
+44 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CV6 Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 02-Nov-2022 $3.39M Completed Clinical Trials - General
3. Later Stage VC 02-Nov-2022 Completed Clinical Trials - General
2. Later Stage VC 03-Mar-2021 Completed Clinical Trials - General
1. Early Stage VC 24-May-2016 Completed Pre-Clinical Trials
To view CV6 Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CV6 Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a drug development company intended to treat human diseases and cancer. The company analyzes cancer cells fo
Drug Discovery
Belfast, United Kingdom
10 As of 2025

Charlottesville, VA
 

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CV6 Therapeutics Competitors (59)

One of CV6 Therapeutics’s 59 competitors is HemoShear Therapeutics, a Venture Capital-Backed company based in Charlottesville, VA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HemoShear Therapeutics Venture Capital-Backed Charlottesville, VA
viDA Therapeutics Venture Capital-Backed Vancouver, Canada
NGM Biopharmaceuticals Private Equity-Backed South San Francisco, CA
Aculys Formerly VC-backed Tokyo, Japan
Regenerx Formerly VC-backed Rockville, MD
You’re viewing 5 of 59 competitors. Get the full list »

CV6 Therapeutics Patents

CV6 Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026156174-A1 Parp inhibitor combination therapy with deoxyuridine triphosphatase inhibitors Pending 16-Jan-2025
AU-2021297566-A1 Combination therapy with deoxyuridine triphosphatase inhibitors Pending 26-Jun-2020
CA-3185648-A1 Combination therapy with deoxyuridine triphosphatase inhibitors Pending 26-Jun-2020
EP-4171549-A1 Combination therapy with deoxyuridine triphosphatase inhibitors Active 26-Jun-2020
EP-4171549-B1 Combination therapy with deoxyuridine triphosphatase inhibitors Active 26-Jun-2020 A61K31/4166
To view CV6 Therapeutics’s complete patent history, request access »

CV6 Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CV6 Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Clarendon Fund Managers Venture Capital Minority
Techstart Ventures Venture Capital Minority
European Regional Development Fund (Brandenburg) Government Minority
Forepont Capital Partners Venture Capital Minority
Invest Northern Ireland Limited Partner Minority
You’re viewing 5 of 6 investors. Get the full list »

CV6 Therapeutics FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process